In this episode, Michael Evans, RPh, MBA, FASHP, Chief Pharmacy Officer for Enterprise Pharmacy at Geisinger, discusses key pharmacy priorities including biosimilar adoption, the impact of the Inflation Reduction Act, cell and gene therapy readiness, and strategies to expand access and strengthen pharmacy operations.
Michael Evans, RPh, MBA, FASHP, Chief Pharmacy Officer for Enterprise Pharmacy at Geisinger,
Next Up in Becker's Healthcare Podcast Episodes
-
In this episode, Dr. David Klein, Partner and MD, Kennedy-White Orthopaedic Center, discusses how AI is improving scheduling, documentation, and…
-
In this episode, Robert Stone, Chief Executive Officer, Helen and Morgan Chu Chief Executive Officer Distinguished Chair, City of Hope,…
-
Josh Orzel on Building the Next Generation of Nursing Leaders and Supporting the Frontline Workforce In this episode, Josh Orzel, Chief Nursing Officer, Saline Health System, discusses strengthening nursing culture, developing talent pipelines and supporting…
Comments are closed.